ARVO Foundation Announces 2021
Pfizer Ophthalmics Carl Camras Translational Research Award Recipient
Young investigator awarded $12,000 for translational research


Rockville, Md.The Association for Research in Vision and Ophthalmology (ARVO) today announced the recipient of the Pfizer Ophthalmics Carl Camras Translational Research Award. The 2021 awardee is Alex Huang, MD, PhD, of the Doheny Eye Institute and University of California in Los Angeles. The award, funded by Pfizer Ophthalmics through the ARVO Foundation, honors Dr. Carl Camras, who is highly respected for his work as a glaucoma specialist and a research scientist. Up to three $12,000 awards are granted annually to young investigators working in areas of translational research.

The intent of the award is to recognize young researchers (45 and younger) who have exhibited excellence in research and their fundamental scientific discoveries, concepts and novel technologies which have led to, or have the promise of leading to, clinical application.

This year’s awardee certainly lives up to that promise. Huang, the inaugural faculty member of the Doheny Eye Institute, Stein Institute and UCLA affiliation, is an ophthalmology clinician-scientist. He trained at The Johns Hopkins University School of Medicine with Lasker Award winner Dr. Solomon Snyder in the Solomon H. Snyder Department of Neuroscience. After completing his residency at the University of Southern California (USC) and Doheny Eye Institute, Huang left USC to complete his glaucoma fellowship with Dr. Robert Weinreb at Shiley Eye Institute.

Huang’s research currently focuses on better understanding fluid flow in and around the eye as a means to better combat glaucomatous optic neuropathy and Space-flight Associated Neuro-ocular Syndrome. “My career goal is to achieve translational success by applying basic research discoveries toward clinical benefit,” he says. To this end, Huang is currently supported by the National Eye Institute (NEI) via an R01 award, and by the National Aeronautics and Space Administration (NASA).

The recipient of numerous awards throughout his early career, Huang says he is especially honored to be recognized by the ARVO Foundation with the Pfizer Ophthalmics Carl Camras Translational Research Award.

“As a glaucoma clinician-scientist, I am further grateful to be linked to an award honoring Dr. Carl Camras who was himself a glaucoma clinician-scientist and who developed prostaglandin analogues into the leading glaucoma therapy today,” says Huang. “Dr. Camras serves as a role model to me by demonstrating the value of fundamental research, the perseverance to overcome hurdles, and the ingenuity to convert basic discoveries to patient benefit.”

For more information about the Pfizer Ophthalmics Carl Camras Translational Research Award, visit ARVO’s website.

# # #

The Association for Research in Vision and Ophthalmology (ARVO) is the largest eye and vision research organization in the world. Members include approximately 10,000 eye and vision researchers from over 75 countries. ARVO advances research worldwide into understanding the visual system and preventing, treating and curing its disorders. Learn more at

Established in 2001, the ARVO Foundation for Eye Research raises funds through partnerships, grants and sponsorships to support ARVO’s world-class education and career development resources for eye and vision researchers of all stages of career and education. Learn more at

Media contact:

Erin Hering